Early Itch and Skin Pain Responses With Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of the Phase 3 JADE COMPARE and JADE DARE Trials
Anthony Bewley, Sonja Ständer, Brian S. Kim, Jonathan I. Silverberg, Laurent Misery, Pinaki Biswas, Gary Chan, Daniela E. Myers, Justine Alderfer, Erman Güler, Melissa Watkins
EADV 2024
- 欧洲皮肤病与性病学会年会 2024
| 皮肤病 | 特应性皮炎
Herpes Zoster and Herpes Simplex Infections in Patients From Japan and Korea With Moderate-to-Severe Atopic Dermatitis Following Treatment With Abrocitinib in the JADE Clinical Programme
Shinichi Imafuku, Tomohiro Hirose, Masayo Yumoto, Sung Beom Chung, Kanti Chittuluru,,* Herwig Koppensteiner, Mizuki Yoshida, Sang-Hyun Cho, Daisuke Watanabe
EADV 2024
- 欧洲皮肤病与性病学会年会 2024
| 皮肤病 | 特应性皮炎
Systemic JAK1 Inhibition by Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis Is Associated With Decreased Lesional Skin Staphylococcus aureus Abundance and Increased Microbial Diversity
Madeline Kim, Ester Del Duca, Joel Correa Da Rosa, Juliana Pulsinelli, Yeriel Estrada, Dan Xu, Gary Chan, Allshine Chen, Erman Güler,
Karen Page,5 Emma Guttman-Yassky1
EADV 2024
- 欧洲皮肤病与性病学会年会 2024
| 皮肤病 | 特应性皮炎
Baseline Demographics and Disease Characteristics Among Patients With Atopic Dermatitis Who Initiate Abrocitinib: Real-World Data From the Dream to TREAT AD Study
Niels S. Krogh,* David Prieto-Merino,* Bolaji Coker,* Thomas Birkner, Elizaveta Gribaleva, Erman Güler, Abaigeal Jackson, Ahmet Akkoc, Axel Hertzschuch, Wouter Ouwerkerk, Con Hennessy, Lara Cutlar, Godfrey Fletcher, Louise A. Gerbens, Arienna Hyseni,
Alan D. Irvine, Rayka Malek, Ida Vittrup, Phyllis I. Spuls, Simon F. Thomsen, Stephan Weidinger, Thomas Werfel, Jochen Schmitt, Carsten Flohr,3 on behalf of the SCRATCH DK, TREATgermany, TREAT NL/BE, and UK-Irish A-STAR Register Study Groups
*Joint first authors.
EADV 2024
- 欧洲皮肤病与性病学会年会 2024
| 皮肤病 | 特应性皮炎
